What it sells
StimCardio Medical is developing a non-invasive wearable neuromodulation platform combining continuous physiological sensing with personalized therapy, starting with atrial fibrillation; investigational, not yet cleared.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-29 | Series A | $30M | — | prnewswire.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-29.